EMV 3.47% $2.09 emvision medical devices ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,520 Posts.
    lightbulb Created with Sketch. 2703
    The last Quarterly - 31 Jul - stated that the Breakthrough Designation application had been submitted. But we don't know the date. Was it weeks before the 31st or just a day or so?

    If it was close to 31 Jul, the 60 day assessment period would imply an outcome by the end of September.

    But based on a recent assessment - at link below - it could be much sooner. Thirty days for Acoustiic (a medical ultrasound imaging device).

    So, imo, we could - if FDA is happy with the submission and not requiring additional clarifications - get the announcement any day.

    This blog is well worth a read for the simple explanation of the benefits of and the processes for securing BD - and the relatively minor implications of not getting it. That is, it is far from a binary situation.

    https://www.fusfoundation.org/the-f...-at-obtaining-breakthrough-device-designation
 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.